Back
Upland Software Vs. Summit Therapeutics Industry Stock Comparison
Sell
30
UPLD
Upland Software
Last Price:
2.41
Seasonality Move:
-7.95%
Buy
79
SMMT
Summit Therapeutics
Last Price:
24.55
Seasonality Move:
26.72%
Sell
30
Upland Software (UPLD)
is a Sell
Is Upland Software a Buy, Sell or Hold?
- The current Upland Software [UPLD] share price is $2.25. The Score for UPLD is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- UPLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $26.22. The Score for SMMT is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UPLD Stock Price Chart
What is Upland Software's stock price today?
-
The Upland Software share price today is $2.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UPLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $26.22
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
UPLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 51.82 | Buy |
Chaikin Money Flow: | 121839 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.07 - 2.27) | Buy |
Bollinger Bands (100): | (2.14 - 2.74) | Sell |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.4 | Buy |
Relative Strength Index (14 RSI): | 69.61 | Buy |
Chaikin Money Flow: | -7453022 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.89 - 22.53) | Buy |
Bollinger Bands (100): | (4.23 - 14.99) | Buy |
UPLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Sell |
20-day SMA: | 2.2 | Buy |
50-day SMA: | 2.24 | Buy |
200-day SMA: | 3.03 | Sell |
8-day EMA: | 2.24 | Buy |
20-day EMA: | 2.21 | Buy |
50-day EMA: | 2.27 | Sell |
200-day EMA: | 2.97 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.01 | Buy |
20-day SMA: | 17.36 | Buy |
50-day SMA: | 13.03 | Buy |
200-day SMA: | 6.61 | Buy |
8-day EMA: | 24.48 | Buy |
20-day EMA: | 19.28 | Buy |
50-day EMA: | 14.43 | Buy |
200-day EMA: | 8.04 | Buy |
Upland Software Earnings Growth & UPLD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.29 per share, and an increase next year of $0.02 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Upland Software Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |